Preclinical Evaluation and Optimization of a Cell Therapy Using Human Cord Blood-Derived Endothelial Colony-Forming Cells for Ischemic Retinopathies. (2018)
Attributed to:
Queen’s P2D 2017: Building on Successful Foundations and Developing New Approaches
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/sctm.17-0187
PubMed Identifier: 29164803
Publication URI: http://europepmc.org/abstract/MED/29164803
Type: Journal Article/Review
Volume: 7
Parent Publication: Stem cells translational medicine
Issue: 1
ISSN: 2157-6564